TOP TIERMARKET NEWSWIRE
News & sentiment

BIOMARIN PHARMACEUTI (BMRN) — News & AI sentiment

BIOMARIN PHARMACEUTI (BMRN) news roundup. 1 story in the last 24 hours, 8 in the past week, 57 over 30 days. Average 24-hour sentiment is 63/100 — bullish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $1.2M — net selling of $1.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 63/100
7d stories
8
avg sentiment 58.6/100
30d stories
57
avg sentiment 59.3/100
Insider net (90d)
$1.2M
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

BMRN news in the last 24 hours, 7 days, 30 days and 90 days

How much BMRN coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBMRN storiesAvg AI sentimentRead
Last 24 hours163/100BMRN headlines →
Last 7 days858.6/100BMRN headlines →
Last 30 days5759.3/100BMRN headlines →
Last 90 days9059.8/100BMRN headlines →

Latest stories on BMRN

17h ago
3d ago
3d ago
H.C. Wainwright reiterates Biomarin stock rating at neutral
Investing.com Analyst Ratings50 · neutralanalyst
3d ago
3d ago
4d ago
4d ago
4d ago
Sep 4
Sep 4
Sep 2
Sep 2
Sep 1
Piper Sandler raises BioMarin stock price target on IP settlement
Investing.com Analyst Ratings63 · neutralanalyst
Sep 1
Sep 1
Sep 1
Sep 1
Sep 1
Canaccord reiterates BioMarin stock rating on Ascendis settlement
Investing.com Analyst Ratings50 · neutralanalyst
Sep 1
Sep 1
Aug 31
Jefferies raises BioMarin stock price target on Ascendis settlement
Investing.com Analyst Ratings63 · neutralanalyst
Aug 31
Morgan Stanley reiterates BioMarin stock rating on settlement value
Investing.com Analyst Ratings56 · neutralanalyst
Aug 31
Aug 31
Aug 31
Open BMRN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →